Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
40.68
-1.40 (-3.33%)
Aug 18, 2026, 4:00 PM EDT - Market closed
Veracyte Employees
Veracyte had 755 employees as of December 31, 2025. The number of employees decreased by 69 or -8.37% compared to the previous year.
Employees
755
Change (1Y)
-69
Growth (1Y)
-8.37%
Revenue / Employee
$744,238
Profits / Employee
$151,633
Market Cap
3.27B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 755 | -69 | -8.37% |
| Dec 31, 2024 | 824 | 9 | 1.10% |
| Dec 31, 2023 | 815 | 28 | 3.56% |
| Dec 31, 2022 | 787 | 26 | 3.42% |
| Dec 31, 2021 | 761 | 441 | 137.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| GRAIL | 910 |
| CareDx | 765 |
| Adaptive Biotechnologies | 624 |
VCYT News
- 7 days ago - Veracyte Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 14 days ago - Veracyte price target lowered to $44 from $47 at Morgan Stanley - TheFly
- 14 days ago - Veracyte price target lowered to $55 from $68 at Stephens - TheFly
- 14 days ago - Veracyte price target lowered to $54 from $66 at Piper Sandler - TheFly
- 15 days ago - Veracyte price target lowered to $50 from $60 at Canaccord - TheFly
- 18 days ago - Veracyte falls -24.1% - TheFly
- 18 days ago - Veracyte falls -24.0% - TheFly
- 18 days ago - Veracyte price target raised to $69 from $57 at Needham - TheFly